Accueil > Résultats de la recherche > Suite de la communication

Evaluating the Long- Term Immunogenicity of Ad / MVA Ebola Virus Vaccines following late boosting with AD26-ZEBOV vaccine administered after heterologous prime/boost schedules of adenoviral and MVA vectored Ebola vaccines in healthy Senegalese adult volunteers aged 18-50 years: an open-label clinical trial,



Date de debut : 25 March 2019
Date de fin : 25 March 2019
Lieu : IRESSEF
Type : Séminaire
Mise en ligne par : DIEYE Tandakha Ndiaye